Transfer Pricing Regulations in India: An Overview
We introduce the transfer pricing regulations in India, including the master file and CbCR requirements. This article is part one of a four-part series.
Stay updated with breaking news from Master File. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
We introduce the transfer pricing regulations in India, including the master file and CbCR requirements. This article is part one of a four-part series.
BILLA Gatesa i Jeffreyja Epsteina povezali su američka neuroznanstvenica i hrvatski imunolog, piše Rolling Stone.
Pennsylvania [US], June 11 (ANI): Bharat Biotech's US partner Ocugen Inc said that the company will no longer pursue an Emergency Use Authorization (EUA) for COVAXIN and the US Food and Drug Administration (FDA) has recommended that the company go for the Biologics Licence Application (BLA) route, which is for full approval, with additional data.
Bharat Biotech's US partner Ocugen said it would no longer seek emergency approval for Covaxin, and would rather file for full approval of the anti-COVID shot
The FDA's verdict is the second roadblock Bharat Biotech has faced with respect to rolling Covaxin out in other parts of the world.